Trial Profile
Multicentre phase II study of KD 025 for the treatment of lupus nephritis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2013
Price :
$35
*
At a glance
- Drugs Belumosudil (Primary)
- Indications Lupus nephritis
- Focus Therapeutic Use
- Sponsors Kadmon Corporation
- 27 Nov 2013 New trial record